Domain or test | Medication variables | Substance abuse variables | Demographic variables | Significant correlations after controlling for two other correlates |
---|---|---|---|---|
Attention (T2) | Opioid substitution drug .48 ( p = 0.003) Number of other psychoactive drugs (T2) .24 | Opioid abuse onset age .25 | Â | Opioid substitution drug .46, ( p = 0.004) |
Attention (T3) | Opioid substitution drug .37 ( p = .024) | Opioid abuse onset age .28 | Age .26 | Opioid substitution drug .37, ( p = 0.021) |
The Letter-Number Sequencing Task (T2) | Number of other psychoactive drugs .25 | Frequency of substance abuse in the past month -49 ( p = .002) | Verbal IQ .29 | Frequency of substance abuse in the past month -44 ( p = .005) |
The Letter-Number Sequencing Task (T3) | Benzodiazepine dose .-38 | Frequency of substance abuse in the past month .-34 ( p = .044) Years of opioid abuse .28 | Â | Â |
Change score in the Letter-Number Sequencing Task (T3 - T2) | Opioid substitution drug .34 ( p = .039) | Â | Change in the opioid agonist dose -.33 Change in the number of psychoactive drugs -.24 | Â |
Verbal memory (T2) | Number of other psychoactive drugs (T2) .25 | Frequency of substance abuse in the past month -. 34 ( p = .044) | Verbal IQ .28 | Â |
Verbal memory (T3) | Number of other psychoactive drugs (T3) .31 | Â | Verbal IQ .32 Years of education .27 | Number of other psychoactive drugs .34 ( p = .035) |